In situ forming implants (ISI) based on phase separation by solvent exchange represent an
attractive alternative to conventional preformed implants and microparticles for parenteral …

Introduction Drug delivery systems with extended-release profiles are ideal in improving
patient compliance with enhanced efficacy. To develop devices capable of a prolonged …

Bioresorbable electronics refer to a new class of advanced electronics that can completely
dissolve or disintegrate with environmentally and biologically benign byproducts in water …

In situ forming (ISF) drug delivery implants have gained tremendous levels of interest over
the last few decades. This is due to their wide range of biomedical applications such as in …

An aging population in the developing world has led to an increase in musculoskeletal
diseases such as osteoporosis and bone metastases. Left untreated many bone diseases …

The apparent difficulty to precisely control fine-tuning of biomaterial degradation has
initiated the recent paradigm shift from conventional top-down fabrication methods to more …

In situ forming systems can serve as promising alternative to existing long acting injectables
like disperse systems and microspheres, owing to their biocompatibility, stability, ease of …

Exposure to maternal stress (MS) and mutations in GAD1, which encodes the γ-aminobutyric
acid (GABA) synthesizing enzyme glutamate decarboxylase (GAD) 67, are both risk factors …

Among the various drug delivery routes, the oral route has long been the most popular and
convenient route. In this chapter, we focus on the development of oral solid dosage forms …

Nanoparticles (NP) that target bone tissue were developed using PLGA–PEG (poly (lactic-co-
glycolic acid)–polyethylene glycol) diblock copolymers and bone-targeting moieties based …